TickerFacts.

Company research / MEDP

Medpace Holdings, Inc. (MEDP)

Build a valuation ↗↓ Download CSV

CIK 0001668397 · Nasdaq · Services-Commercial Physical & Biological Research

  • Sector Services
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Medpace Holdings, Inc. reported revenue of $2.53B. Revenue grew 20.0% from the prior annual period. Over the twelve months to 2026-09-30, revenue was $2.84B.

Key ratios (year ended 2025-12-31)

21.1%
Operating margin
17.8%
Net margin
98.3%
Return on year-end equity
20.0%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 10-Q (quarterly report) · 2026-10-22

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-09-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-09-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$2.84B$2.53B$2.11B$1.89B$1.46B$1.14B$925.92M$860.97M$704.59M$436.15M$421.58M
Operating Income$607.14M$534.93M$446.87M$336.82M$278.70M$198.62M$167.04M$127.26M$101.05M$64.86M$52.49M
Net Income$517.83M$451.12M$404.39M$282.81M$245.37M$181.85M$145.38M$100.44M$73.19M$39.12M$13.43M
EPS (Diluted)n/a$15.28$12.63$8.88$7.28$4.81$3.84$2.67$1.97$0.98$0.37
Total Assets$2.30B$1.98B$2.10B$1.66B$1.35B$1.66B$1.39B$1.14B$967.93M$950.72M$979.11M
Total Liabilities$1.72B$1.52B$1.28B$1.10B$966.11M$707.01M$584.90M$416.79M$378.23M$447.19M$368.39M
Long-Term Debtn/an/an/an/an/an/an/an/an/an/a$165.00M
Shareholders' Equity$584.94M$459.07M$825.54M$558.95M$386.39M$952.93M$805.78M$726.28M$598.86M$503.53M$610.71M
Cash & Equivalents$705.32M$497.05M$669.44M$245.45M$28.27M$461.30M$277.77M$131.92M$23.27M$26.48M$37.10M
Operating Cash Flow$723.05M$713.22M$608.82M$433.37M$388.05M$263.33M$258.68M$201.87M$156.58M$97.39M$91.73M
Capital Expenditures$55.42M$31.36M$36.55M$36.65M$36.88M$28.27M$31.34M$17.91M$16.02M$11.72M$13.54M
Free Cash Flow$667.63M$681.87M$572.27M$396.73M$351.17M$235.06M$227.34M$183.96M$140.56M$85.66M$78.19M
Share Repurchases$294.76M$917.39M$169.87M$144.02M$847.85M$62.10M$98.27M$0$0$155.58M$0
Shares Outstanding27.97M28.37M30.63M30.75M31.09M36.01M35.52M36.07M35.67M35.47M40.66M
Weighted Average Diluted Sharesn/a29.53M32.01M31.84M33.67M37.70M37.71M37.58M36.91M39.84M36.33M
EPS (Basic)n/a$15.64$13.06$9.20$7.57$5.06$4.07$2.79$2.05$1.00$0.38

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView